Clinical Trial

Tobacco Education and Lung Health Study (TEAL)

Study acronym: TEAL
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-26; most recent amendment 2026-02-13.
Trial Details
NCT Number NCT06290869
Lead Sponsor Georgetown University
Conditions Smoking Cessation
Enrollment 1,188 participants
Start Date 2024-02-22
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-17